Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Palisade Bio Inc PALI

Palisade Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal diseases. It is engaged in advancing a PALI-2108 for the treatment of IBD, including UC and CD and are researching PALI-1908. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract. UC primarily affects the colon and the rectum. CD... see more

NDAQ:PALI - Post Discussion

Palisade Bio Inc > Dow Edges Lower; Cardlytics Shares Jump | Benzinga
View:
Post by whytestocks on Jan 29, 2024 12:30pm

Dow Edges Lower; Cardlytics Shares Jump | Benzinga

Just In: $PALI Dow Edges Lower; Cardlytics Shares Jump | BenzingaU.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday.The Dow traded down 0.04% to 38,093....PALI - Dow Edges Lower; Cardlytics Shares Jump | Benzinga
Be the first to comment on this post